EPO Patents = 4

Forward Citations = 12

Loading Chart...

1 inventor (with patents filed for the assignee):

John J Nestor (5 out of 13 patents)

5 patents: Sort by Forward Citations

1. 11911447 - Peptide pharmaceuticals for insulin resistance (2024-02-27),

2. 11065304 - Peptide pharmaceuticals for insulin resistance (2021-07-20),

3. 10577405 - Peptide pharmaceuticals for insulin resistance (2020-03-03),

4. 10471127 - Peptide pharmaceuticals for insulin resistance (2019-11-12),

5. 10420844 - Peptide pharmaceuticals (2019-09-24),

Mederis Diabetes, LLC is a leading provider of innovative diabetes management solutions. With a focus on helping individuals with diabetes live healthier and more fulfilling lives, Mederis offers a range of products and services including glucose monitoring devices, insulin pumps, and personalized support programs. Their team of experts is dedicated to improving the quality of life for those living with diabetes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

5 Patents

#39 in Sugar Land, TX

#3,244 in Texas

#50,174 in US

Sugar Land, TX, United States of America

Mederis Diabetes, LLC

Forward Citations = 12

1 inventor:

John J Nestor (5 out of 13 patents)

Please report any incorrect information to support@idiyas.com

4 patents (EPO):

Please report any incorrect information to support@idiyas.com